WISEneuro is an innovative biomedical company specializing in the development of advanced medical devices for neuromodulation and neuromonitoring. The company is headquartered in Cologno Monzese, Italy, and has garnered significant attention and investment, including a €15 million Series C funding round and an EC grant through the EIC Accelerator Programme.

WISEneuro focuses on creating implantable leads and electrodes that are stretchable, flexible, and biocompatible. These devices are designed to provide effective stimulation with minimal invasiveness, making them suitable for treating chronic pain and monitoring epilepsy. The company's technology represents a significant advancement in lead manufacturing, transitioning from rigid to stretchable materials that offer better adhesion and adaptability.

The primary clients of WISEneuro are healthcare providers and medical institutions that treat patients with chronic pain and epilepsy. The market for these medical devices is growing, driven by an increasing prevalence of neurological disorders and a rising demand for minimally invasive treatments.

WISEneuro operates on a business model that involves the research, development, and commercialization of its proprietary medical devices. The company generates revenue through the sale of these devices to hospitals, clinics, and other medical facilities. Additionally, WISEneuro may engage in partnerships and collaborations with other healthcare companies to expand its market reach and enhance its product offerings.

In summary, WISEneuro is at the forefront of biomedical innovation, providing advanced solutions for neuromodulation and neuromonitoring. The company's cutting-edge technology and strategic funding position it well for continued growth and impact in the medical device industry.

Keywords: neuromodulation, neuromonitoring, chronic pain, epilepsy, medical devices, implantable leads, flexible electrodes, biomedical innovation, healthcare, minimally invasive.